Company Bionime Corporation

Equities

4737

TW0004737002

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
69.9 ^TWD	-1.13%		+2.79%	-6.55%

03-15	Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.

TWD in Million	2022	Weight	2023	Weight	Delta
Blood Glucose Meter and Test Piece 100.0 %	-	-	1,756	100.0 %	-

TWD in Million	2022	Weight	2023	Weight	Delta
Other Countries 42.7 %	838	37.9 %	749	42.7 %	-10.55%
Algeria 19.4 %	729	33.0 %	341	19.4 %	-53.22%
China 14.3 %	299	13.5 %	252	14.3 %	-15.85%
United States 11.6 %	177	8.0 %	204	11.6 %	+15.27%
Switzerland 5.8 %	136	6.2 %	102	5.8 %	-25.51%
United Arab Emirates 5.1 %	-	-	89	5.1 %	-
Egypt 1.1 %	31	1.4 %	19	1.1 %	-40.49%

Managers	Title	Age	Since
Chun Mu Huang CEO	Chief Executive Officer	-	13/04/03
Hui Chen Chen DFI	Director of Finance/CFO	-	05/11/17
Zhi Long Yeh CTO	Chief Tech/Sci/R&D Officer	-	06/11/18
Pi Hsuan Chen CTO	Chief Tech/Sci/R&D Officer	-	31/01/16
Yu Jen Hsu COO	Chief Operating Officer	-	31/01/16
Tai Hsiung Chiang BRD	Director/Board Member	-	16/10/07
Marvin Wu SAM	Sales & Marketing	-	03/08/22
Ya Wen Chen AUD	Comptroller/Controller/Auditor	-	01/01/21
Wiley Chung PRN	Corporate Officer/Principal	-	-
Ming-Lun Zhang PRN	Corporate Officer/Principal	-	06/11/18

Members of the board	Title	Age	Since
Chun Mu Huang CEO	Chief Executive Officer	-	13/04/03
Tai Hsiung Chiang BRD	Director/Board Member	-	16/10/07
Chung Kai Tai BRD	Director/Board Member	-	14/05/07
Mei An Liu BRD	Director/Board Member	-	04/07/22
Chien Hsing Lin BRD	Director/Board Member	-	27/06/13
Chin Pin Su BRD	Director/Board Member	-	04/02/16
Xiu Mei Liou BRD	Director/Board Member	-	24/03/10
Wen Hai Zhang BRD	Director/Board Member	-	19/06/19
Hui Jin Zeng BRD	Director/Board Member	-	04/07/22
Rui Xin Chen BRD	Director/Board Member	-	04/07/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	60,942,394	32,849,394 ( 53.90 %)	0	53.90 %

Name	Equities	%	Valuation
DFA Australia Ltd. 0.002241 %	1,363	0.002241 %	3 003 NT$

Bionime Corp.

No. 100, Section 2, Daqing Street South District

402 42, Taichung

http://www.bionime.com

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

69.9 TWD

Average target price

80 TWD

Spread / Average Target

+14.45%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
BIONIME CORPORATION	-6.55%	131M
BIOMÉRIEUX	-1.29%	12.64B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.47%	8.46B
LANTHEUS HOLDINGS, INC.	+22.61%	5.27B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.03%	4.49B
10X GENOMICS, INC.	-53.56%	3.11B
ANDON HEALTH CO., LTD.	+19.30%	2.87B
MYRIAD GENETICS, INC.	+33.07%	2.31B
VITROLIFE AB	-8.42%	2.23B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-3.55%	1.89B

Diagnostic & Testing Substances